Segal David
Centre for Diabetes and Endocrinology, 18 Eton Road, Parktown, Johannesburg 2198.
S Afr Med J. 2009 Mar;99(3 Pt 2):187-95.
The Paediatric and Adolescent Endocrine and Diabetes Society of South Africa (PAEDS-SA) recommends, in line with other international groups, that growth hormone (GH) therapy be considered for children and adolescents with significantly short stature and poor growth velocity in the following instances: GH deficiency; Turner syndrome; Prader-Willi syndrome; small-for-gestational-age children with failure of catch-up growth; idiopathic short stature; and chronic renal insufficiency. We have produced treatment guidelines for the use of GH, designed to allow flexibility to determine coverage on a case-by-case basis. We further recommend that when used for growth promotion, GH therapy should be initiated and monitored by, or in consultation with, a paediatric endocrinologist.
南非儿科与青少年内分泌及糖尿病学会（PAEDS-SA）与其他国际组织一致建议，在以下情况下，应考虑对身材显著矮小且生长速度缓慢的儿童和青少年进行生长激素（GH）治疗：生长激素缺乏症；特纳综合征；普拉德-威利综合征；小于胎龄儿且追赶生长失败；特发性矮小；以及慢性肾功能不全。我们制定了生长激素使用的治疗指南，旨在允许根据具体情况灵活确定保险范围。我们还建议，当生长激素用于促进生长时，治疗应由儿科内分泌学家启动并监测，或在其咨询下进行。
